Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$35.24 - $47.1 $88,029 - $117,655
-2,498 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $21,717 - $23,948
531 Added 27.0%
2,498 $110,000
Q4 2021

Feb 15, 2022

SELL
$38.07 - $44.87 $440,622 - $519,325
-11,574 Reduced 85.47%
1,967 $83,000
Q3 2021

Nov 16, 2021

BUY
$41.23 - $45.88 $20,037 - $22,297
486 Added 3.72%
13,541 $475,000
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $321,024 - $368,121
8,321 Added 175.77%
13,055 $558,000
Q1 2021

Oct 07, 2021

BUY
$35.27 - $39.67 $166,968 - $187,797
4,734 New
4,734 $183,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $566,367 - $717,057
-17,085 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$34.44 - $42.23 $588,407 - $721,499
17,085 New
17,085 $652,000
Q2 2020

Aug 17, 2020

SELL
$30.19 - $39.11 $408,802 - $529,588
-13,541 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$30.19 - $39.11 $243,965 - $316,047
8,081 Added 148.0%
13,541 $475,000
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $141,031 - $249,576
5,460 New
5,460 $178,000
Q4 2019

Feb 13, 2020

SELL
$37.87 - $45.37 $19,881 - $23,819
-525 Closed
0 $0
Q3 2019

Nov 21, 2019

BUY
$40.31 - $43.45 $21,162 - $22,811
525 New
525 $22,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.